Exiqon
Home Search Contact Print
0 items in basket0
Sign In
 
 
Products Services Applications Resource Center Ordering About Exiqon
microRNA Research
lncRNA Research
mRNA Research
DNA Research
Custom Oligos
Other Reagents
RNA Isolation
Sequencing
Microarray Analysis
Real-time PCR
Northern Blotting
In Situ Hybridization
Functional Analysis
RNA Preparation
Sequencing
Microarray analysis
Real-time PCR
In Situ Hybridization
Antisense
RNA Preparation
Sequencing
Microarray analysis
Real-time PCR
In Situ Hybridization
Antisense
SNP Detection
Sequencing
Microarray Analysis
In Situ Hybridization
LNA Phosphoramidites
A2 Quencher
RNA Isolation Services
microRNA PCR Services
Sequencing Services
XploreRNA
microRNA ISH Services
Custom Pharma Service
Isolation
Microarray Analysis
Northern Blotting
Real-time PCR
In Situ Hybridization
Functional Analysis
SNP Detection
RNA
microRNA
RNA
DNA
microRNA
microRNA
RNA
microRNA
RNA
DNA
microRNA
RNA
DNA
microRNA Resources
mRNA and lncRNA Resources
Documents
Reading rooms
Application Stories
Technology
Oligo design tools
Movies
microRNA
Research Guide
Reading rooms
Application Stories
Bioinformatics and data analysis
What are lncRNAs?
Application Stories
Bioinformatics
Oligo modifications
LNA™
AQ-link
Order microRNA products
Order custom oligos
Distributors
Global Service Providers
General Information
Contact
News
History
Management
Board of Directors
Newsletter
Career
Sign up to Newsletter
Newsletter Back Issues
 

RNA functional analysis screening

Custom plates with LNA™ GapmeRs for RNA functional analysis screening projects, conveniently delivered in 96-well format.



Antisense LNA™ GapmeRs best-in-class in comparative study

Biogazelle is a Belgian company focusing on developing novel RNA-targeting therapies in cancer. In a comparative study they tested the performance of Antisense LNA™ GapmeRs alongside other technologies for RNA silencing.

Exiqon designed custom plates with 200 LNA™ GapmeRs targeting long non-coding RNAs selected by Biogazelle. The LNA™ GapmeRs were tested for potency (knockdown efficiency) in two different cancer cell lines.

LNA™ GapmeRs showed a success rate that was more than twice as high as the second best performing technology and consequently Biogazelle chose LNA™ GapmeRs as their preferred technology for screening lncRNA cancer therapeutic targets.

"We are extremely satisfied with the performance of Exiqon's Antisense LNA™ GapmeRs for knockdown of lncRNAs. With this set of encouraging results, we are very excited about the prospect of utilizing Exiqon's platform for target validation and potential development of a new type of drugs targeting lncRNA".

Jo Vandesompele, Biogazelle CSO





Custom plates with LNA™ GapmeRs for RNA functional analysis screening projects

Antisense LNA™ GapmeRs are available in convenient 96-well plate format useful for:
  • Identification of super-potent LNA™ GapmeRs by screening multiple LNA™ GapmeRs per RNA target
  • Loss of function screening of multiple RNAs in parallel
Custom plate details:
  • LNA™ GapmeRs with custom defined purity and amount, delivered dried down in 96-well plates
  • Minimum order 18 LNA™ GapmeRs
  • Fully flexible plate layout
  • Affordable – please contact us for pricing
  • To order please contact us with your list of LNA™ GapmeRs

How to order



Contact our RNA functional analysis experts to discuss your screening project and order your custom plates.



  Privacy   Sitemap   Legal